Shattuck Labs (STTK) Gains from Investment Securities (2019 - 2026)
Shattuck Labs (STTK) reported Gains from Investment Securities of $262000.0 for Q1 2026, up 303.08% year-over-year from $65000.0 in Q1 2025, and up 303.08% quarter-over-quarter from $65000.0 in Q1 2025.
Shattuck Labs (STTK) Gains from Investment Securities (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has 8 years of Gains from Investment Securities data on file, last reported at $262000.0 in Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $262000.0, up 303.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $262000.0 (up 231.65% YoY), and the FY2025 annual result was $65000.0, down 85.59% from the prior year.
- Gains from Investment Securities improved to $262000.0 in Q1 2026 per STTK's latest filing, from $65000.0 in the prior quarter.
- Over five years, Gains from Investment Securities peaked at $2.9 million in Q2 2022 and troughed at -$2.9 million in Q3 2022.
- A 5-year average of $92333.3 and a median of $39000.0 in 2023 frame the typical range for Gains from Investment Securities.
- The sharpest annual moves came in 2022 and 2024: Gains from Investment Securities plunged 1322.71% in 2022, then soared 1020.51% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at -$2.9 million in 2022, then surged by 100.48% to $14000.0 in 2023, then plunged by 71.43% to $4000.0 in 2024, then surged by 1525.0% to $65000.0 in 2025, then jumped by 303.08% to $262000.0 in 2026.
- Business Quant data shows STTK's Gains from Investment Securities at $262000.0 in Q1 2026, $65000.0 in Q1 2025, and $4000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Shattuck Labs | 190.32 Mn | 190.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 262,000.00 |
| Mar 31, 2026 | 262,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Sep 30, 2024 | 4,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 437,000.00 |
| Mar 31, 2024 | 437,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Dec 31, 2023 | 14,000.00 |
| Mar 31, 2023 | 39,000.00 |
| Mar 31, 2023 | 39,000.00 |
| Sep 30, 2022 | -2.95 Mn |
| Sep 30, 2022 | -2.95 Mn |
| Jun 30, 2022 | 2.95 Mn |
| Jun 30, 2022 | 2.95 Mn |
| Sep 30, 2021 | -207,000.00 |
| Sep 30, 2021 | -207,000.00 |